Investors Mutual co-founder Anton Tagliaferro reveals his take on the new higher interest rate landscape and what that means for investors, and he reveals the ASX-listed companies & sectors he likes, and those he steers away from. He’s also very candid about competition from passive funds and losing some big clients. But he also offers insights into how he survived some of the biggest financial crises of the past 2 decades; and why football in Australia and Malta are a big part of his life.

Investors Mutual co-founder Anton Tagliaferro reveals his take on the new higher interest rate landscape and what that means for investors, and he reveals the ASX-listed companies &amp; sectors he likes, and those he steers away from. He’s also very candid about competition from passive funds and losing some big clients. But he also offers insights into how he survived some of the biggest financial crises of the past 2 decades; and why football in Australia and Malta are a big part of his life.

Candid interviews with successful Self-starters. On Build It. They'll Come, you'll hear from some amazing Australian entrepreneurs who bet big to build great businesses. Journalist Helen Dalley interviews business innovators and visionaries on how they turned their lightbulb idea into a viable, sustainable enterprise. 

This podcast is about the human face behind taking a simple idea and turning it into a business or movement. It's the beating heart behind what it takes to build an empire, from concept to execution, and how they actually achieve it. Fuelled by blind faith and hard slog, how they transform their dream idea into concrete reality.

Journalist Helen Dalley interviews business innovators and visionaries on how they turned their lightbulb idea into a viable, sustainable enterprise.

Build It. They'll Come.

Investors Mutual Ltd – 2/2, astute stock picker Anton Tagliaferro reveals what companies & sectors he likes, and doesn’t like; plus, surviving some of the worst financial crises.

You’ve probably never heard of GROW Super or GROW Inc. And that’s just the way co-founder and CEO Mathew Keeley likes it. But GROW Inc is solving some of the logjam problems in the “back office” administration of our massive Superannuation Funds. GROW Inc instigated a new way for Superannuation fund customers like you and I, to better access and engage with our Super Funds, by creating and building an innovative administration software using blockchain, or Distributed Ledger Technology. GROW Inc claims its platform transforms legacy systems and business models and allows fund managers and their funds to offer more streamlined, real time information to customers about their Super.

So how did a 5th generation farm boy, end up revolutionising the way Superannuation Funds interact with clients and members, giving as easy an experience for fund members as Amazon gives their online shoppers?

And how the heck did Mat Keeley, with a tiny team of only 36 employees at the time, persuade one of the world’s biggest wealth managers, the US giant Vanguard – with something like $10 Trillion in their care – to take a punt on his Super fund “back office” platform GROW Inc?  Well, tune in right now and you’ll find out. Enjoy Mathew Keeley’s extraordinary journey with GROW Inc.

You’ve probably never heard of GROW Super or GROW Inc. And that’s just the way co-founder and CEO Mathew Keeley likes it. But GROW Inc is solving some of the logjam problems in the “back office” administration of our massive Superannuation Funds. GROW Inc instigated a new way for Superannuation fund customers like you and I, to better access and engage with our Super Funds, by creating and building an innovative administration software using blockchain, or Distributed Ledger Technology. GROW Inc claims its platform transforms legacy systems and business models and allows fund managers and their funds to offer more streamlined, real time information to customers about their Super.
So how did a 5th generation farm boy, end up revolutionising the way Superannuation Funds interact with clients and members, giving as easy an experience for fund members as Amazon gives their online shoppers?
And how the heck did Mat Keeley, with a tiny team of only 36 employees at the time, persuade one of the world’s biggest wealth managers, the US giant Vanguard – with something like $10 Trillion in their care – to take a punt on his Super fund “back office” platform GROW Inc?  Well, tune in right now and you’ll find out. Enjoy Mathew Keeley’s extraordinary journey with GROW Inc.

GROW Inc – Mathew Keeley revolutionises Super funds’ admin, using Blockchain, impressing giant Vanguard along the way

Tasmania born, schooled in Hong Kong, now working in Melbourne, scientist Nick Murphy is on the frontier of IVF reproductive medicine. Nick and his small highly skilled team developed a world-first genetic screening test for IVF embryos capable of detecting several thousand severe genetic diseases and life threatening conditions. And it’s done in one single, simple test, via whole genome sequencing of the pre-implantation embryo. It’s commercialised by Nick’s startup, GenEmbryomics. Dr Murphy will offer this test through existing IVF clinics, at as low a price as possible, and to as many couples going through IVF as need it.

While not available commercially yet in Australia, GenEmbryomics is in the process of securing patents for the test in the massive IVF market in the USA, worth some $9billion. There are plans to list the startup on New York’s NASDAQ exchange by mid-2024. It’s been a wild and fascinating journey for this genetic scientist turned entrepreneur, since the GenEmbryomics business began in 2019. Hope you enjoy Dr Nick Murphy.

Tasmania born, schooled in Hong Kong, now working in Melbourne, scientist Nick Murphy is on the frontier of IVF reproductive medicine. Nick and his small highly skilled team developed a world-first genetic screening test for IVF embryos capable of detecting several thousand severe genetic diseases and life threatening conditions. And it’s done in one single, simple test, via whole genome sequencing of the pre-implantation embryo. It’s commercialised by Nick’s startup, GenEmbryomics. Dr Murphy will offer this test through existing IVF clinics, at as low a price as possible, and to as many couples going through IVF as need it. While not available commercially yet in Australia, GenEmbryomics is in the process of securing patents for the test in the massive IVF market in the USA, worth some $9billion. There are plans to list the startup on New York’s NASDAQ exchange by mid-2024. It’s been a wild and fascinating journey for this genetic scientist turned entrepreneur, since the GenEmbryomics business began in 2019. Hope you enjoy Dr Nick Murphy.

GenEmbryomics – Nick Murphy revolutionises reproductive medicine, his new genetic embryo test detects 2,500 genetic diseases

An immigrant child of Polish Jewish parents, Jack Gance ended up disrupting several entire industries with HIS model of shopkeeping through suburban Australia. The pharmacist turned into an entrepreneur by chance really. After gaining his Pharmacy degree, Jack and his brother Sam started with just 1 pharmacy in the early 1970’s, which they slowly built on. Along the journey, Jack Gance totally upended the way traditional pharmacies in Aussie suburbs operate, by essentially making all the other products chemists sell aside from prescriptions, much more enticing and cheaper for shoppers. He also built a distribution business in the process.

After 51 years in business Jack Gance, with Sam and co-founder Mario Verrocchi spent the past two-plus decades building their Chemist Warehouse business and brand into a household name, thereby revolutionising not just the pharmacy model, but the entire retailing landscape, by offering discounts on every product in the store. Now with 500 partner/franchise stores and a recently announced deal to merge with Sigma Healthcare, in order to expand the business, we’re replaying the interview we did in 2023 where Jack reflects, just a little, on that amazing entrepreneurial journey. And why he can’t stop!

An immigrant child of Polish Jewish parents, Jack Gance ended up disrupting several entire industries with HIS model of shopkeeping through suburban Australia. The pharmacist turned into an entrepreneur by chance really. After gaining his Pharmacy degree, Jack and his brother Sam started with just 1 pharmacy in the early 1970’s, which they slowly built on. Along the journey, Jack Gance totally upended the way traditional pharmacies in Aussie suburbs operate, by essentially making all the other products chemists sell aside from prescriptions, much more enticing and cheaper for shoppers. He also built a distribution business in the process.
After 51 years in business Jack Gance, with Sam and co-founder Mario Verrocchi spent the past two-plus decades building their Chemist Warehouse business and brand into a household name, thereby revolutionising not just the pharmacy model, but the entire retailing landscape, by offering discounts on every product in the store. Now with 500 partner/franchise stores and a recently announced deal to merge with Sigma Healthcare, in order to expand the business, we’re replaying the interview we did in 2023 where Jack reflects, just a little, on that amazing entrepreneurial journey. And why he can’t stop!

Chemist Warehouse – Jack Gance revolutionises retailing in Australia, upending the traditional Pharmacy model. And why he wants to expand via a merger with Sigma Healthcare (Replay from the vault).

Investors Mutual Ltd – 2/2, astute stock picker Anton Tagliaferro reveals what companies & sectors he likes, and doesn’t like; plus, surviving some of the worst financial crises.

In 1 playlist(s)

Build It. They'll Come.

Social links

Follow podcast

Recent clips